Because of positive relation between CD4+TILs and tumor outcome, it can be inferred that regulatory subsets may be through downregulation of harmful inflammatory reaction and activated CD4+cells with anti-tumor activity and cytokine secretion could control tumor progression. The gene discussed is CD4; the disease is neoplasm.